Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
life sciences
national blog main
2
×
abaloparatide
akcea therapeutics
alnylam pharmaceuticals
amgen
biotech
boston
boston blog main
boston top stories
clinical trials
drugs
europe blog main
europe top stories
european commission
european medicines agency
harvard pilgrim health care
hereditary transthyretin amyloidosis
inotersen
institute for clinical and economic review
national
national top stories
new york blog main
new york top stories
onpattro
osteoporosis
patisiran
pfizer
radius health
romosozumab
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
tafamidis
teriparatide
ucb
What
drug
europe
medicine
2
×
alnylam
amgen
amgen’s
approval
approves
carries
cells
developed
ema
employ
european
fda
follows
gene
harmful
heart
hits
interference
make
marketing
method
mute
nod
osteoporosis
protein
raise
risk
rna
rnai
uses
warning
way
wins
Language
unset
Current search:
europe���s
×
medicine
×
" national blog main "
×
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug